EMBRACE at Dana-Farber Improves Care in Metastatic Breast Cancer

Share this content:
The EMBRACE program uses a multifaceted approach to improve the lives of those with metastatic breast cancer.
The EMBRACE program uses a multifaceted approach to improve the lives of those with metastatic breast cancer.
The following article features coverage from the 2017 San Antonio Breast Cancer Symposium (SABCS) in San Antonio, Texas. Click here to read more of Oncology Nurse Advisor's conference coverage. 

The Dana-Farber Cancer Institute (DFCI) developed EMBRACE (Ending Metastatic Breast Cancer for Everyone), a comprehensive program implemented in August 2016 designed to improve the care of patients with metastatic breast cancer. A review of the program was presented at the 2017 San Antonio Breast Cancer Symposium (SABCS 2017).

EMBRACE combines clinical care, clinical research, physician engagement, and patient education. At the core of the program is the EMBRACE coordinator, who meets with every patient at their first visit to review the program and available education and supportive resources. The coordinator also supports oncologists, facilitates referrals to supportive care, identifies candidates for trial prescreening, tracks the availability of molecular and clinical trial results, and acts as a liaison between the institute and referring providers. Coordinators also contact patients every 3 months to inquire about their health and needs and to provide updates on forthcoming education and supportive care activities at DFCI.

The program enrolls an average of 30 to 40 new patients per month. “The EMBRACE program has made a tangible improvement in the quality of care for patients with metastatic breast cancer in our clinic,” reported DFCI. “We believe that our approach has the potential for impact beyond our institution, and ultimately serve as a model for enhanced academic-community-patient partnership.”

Reference

Hughes ME, Frank ES, Merrill MS, et al. EMBRACE (Ending metastatic breast cancer for everyone): A comprehensive approach to improve the care of patients with metastatic breast cancer. Poster presentation at: 2017 San Antonio Breast Cancer Symposium; December 6-9, 2017; San Antonio, TX. Abstract P4-10-04.

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs